One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...
John M. Burke, MD, examines how new obesity treatments, such as GLP-1 agonists, might influence future cancer rates.
A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...
Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...
France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
Three cities in Hawaii, Minnesota, and Texas report the highest usage of injectable weight loss medications. Meanwhile, ...
Diabetes is very common. The Centers for Disease Control and Prevention (CDC) notes that 38.4 million people in the United ...
The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...
Shares of WeightWatchers parent company WW International ($WW) have rocketed 40% higher on news that the company plans to ...
New data from the CDC and other leading health agencies shows a number of health markers are beginning to improve in the US - ...
Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback